Ocugen
OCGN----
Ocugen (OCGN)
Ocugen, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel gene and cell therapies, biologic, and vaccines that im...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Ocugen Analyst Rating
View MoreForecast & Rating
Jul 13, 2026Price forecast
$11.43844.51%
Forecast & RatingStrong buy
7analysts
- Strong buy85.71%
- Buy14.29%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- MarketWatch Automated · 4 hours ago
Ocugen Inc. Stock Falls Friday, Underperforms Market
- MarketWatch Automated · 1 day ago, 04:28 PM
Ocugen Inc. Stock Falls Thursday, Underperforms Market
- Market Beat · 1 day ago, 04:11 AM
Ocugen (OCGN) Expected to Announce Earnings on Thursday
- Global Report · 2 days ago, 04:18 AM
US Equities Wire: Marriott's USD 1B Buyback Highlights Shifting Capital Allocation Strategies
- MarketWatch Automated · Jul 21 at 04:27 PM
Ocugen Inc. Stock Falls Tuesday, Underperforms Market
- Global Report · Jul 21 at 04:13 AM
The Great AI Infrastructure Pivot Reaches the Fringes of the Market
